ELRIG UK and SRG announce partnership to advance life science professionals

Partnership endorses mission to facilitate career progression and support life science industry growth

15 Apr 2024
Jessica Calvey
Product and Reviews Admin Assistant

Industry news

The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, today entered into a partnership with SRG, leaders in life science recruitment, to support the advancement of science professionals in their careers.

The partnership offers the ELRIG community access to career opportunities and provides organisations of all sizes with SRG’s specialist talent solutions to help grow the life science sector. In particular, early career professionals (ECPs) in industry and academia can attend forums and networking events where they can meet, and learn the skills needed to help them advance their careers in drug discovery.

ELRIG brings together academic and biopharma industry experts and thought leaders to exchange ideas and information through the provision of free-to-attend scientific meetings and conferences. Its primary objective is to provide leading-edge knowledge to the life sciences community on an open-access basis. As part of the ELRIG events programme, there are a range of activities designed specifically for ECPs. SRG, powered by Impellam Group, are experts in finding the specialist skills needed to support biotech and pharmaceutical research. They help life science companies — from start-ups to big pharma — to find, attract and nurture emerging talent, and aim to ensure outstanding career prospects for candidates. Together ELRIG and SRG will provide support to life science professionals that will allow them to gain a deeper understanding of the industry, select the right career path, and develop the tools needed to progress, while helping the drug discovery industry to flourish.

Sanj Kumar, CEO, ELRIG UK, said, “ELRIG and SRG have a shared ambition to advance the careers of early-stage professionals in drug discovery. ELRIG will provide the opportunities for ECPs to connect, whilst SRG can help them to expand their skillset and progress in their careers. Building such networks is an imperative as they navigate the myriad of collaboration and career options ahead of them. We are delighted to be working with the team at SRG, who bring 30 years of industry experience supporting scientific endeavours to this exciting collaboration.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Combinatorial ChemistryCombinatorial chemistry, also known as combichem, is a technique used in drug discovery to create libraries of structurally related compounds. A library is generated by synthesis with a chemical reactor system or by computer-based modeling of compound combinations. When undertaking combinatorial chemistry consider reagents, buffers, resins and standards.ELRIGDrug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.
ELRIG UK and SRG announce partnership to advance life science professionals